Browse CAMKMT in pancancer

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Domain, Function and Classification > Gene Ontology > KEGG and Reactome Pathway

> Domain, Function and Classification

Domain

PF10294 Lysine methyltransferase

Function

Catalyzes the trimethylation of 'Lys-116' in calmodulin.

Classification

Class	Modification	Substrate	Product	PubMed
#	#	#	#	#

> Gene Ontology [ TOP ]
Biological Process	GO:0006479 protein methylation GO:0007602 phototransduction GO:0007603 phototransduction, visible light GO:0008213 protein alkylation GO:0008277 regulation of G-protein coupled receptor protein signaling pathway GO:0009314 response to radiation GO:0009416 response to light stimulus GO:0009581 detection of external stimulus GO:0009582 detection of abiotic stimulus GO:0009583 detection of light stimulus GO:0009584 detection of visible light GO:0016056 rhodopsin mediated signaling pathway GO:0018022 peptidyl-lysine methylation GO:0018205 peptidyl-lysine modification GO:0022400 regulation of rhodopsin mediated signaling pathway GO:0032259 methylation GO:0043414 macromolecule methylation GO:0071214 cellular response to abiotic stimulus GO:0071478 cellular response to radiation GO:0071482 cellular response to light stimulus
Molecular Function	GO:0008168 methyltransferase activity GO:0008170 N-methyltransferase activity GO:0008276 protein methyltransferase activity GO:0008757 S-adenosylmethionine-dependent methyltransferase activity GO:0016278 lysine N-methyltransferase activity GO:0016279 protein-lysine N-methyltransferase activity GO:0016741 transferase activity, transferring one-carbon groups GO:0018025 calmodulin-lysine N-methyltransferase activity
Cellular Component	-

> KEGG and Reactome Pathway [ TOP ]
KEGG	hsa00310 Lysine degradation
Reactome	R-HSA-2514859: Inactivation, recovery and regulation of the phototransduction cascade R-HSA-392499: Metabolism of proteins R-HSA-597592: Post-translational protein modification R-HSA-8876725: Protein methylation R-HSA-162582: Signal Transduction R-HSA-2514856: The phototransduction cascade R-HSA-2187338: Visual phototransduction

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Mutation landscape in primary tumor tissue from TCGA > Mutation landscape in cancer cell line from CCLE > All mutations from COSMIC database V81 > Variations from text mining

> The Cancer Genome Atlas (TCGA) [ TOP ]

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> Catalogue of Somatic Mutations in Cancer (COSMIC)

COSMIC ID	CDS change	AA change	Mutation Type	Anatomical Site
COSM266138	c.787C>T	p.R263C	Substitution - Missense	Large_intestine
COSM3185392	c.806A>G	p.N269S	Substitution - Missense	Large_intestine
COSM4824821	c.719G>A	p.R240K	Substitution - Missense	Cervix
COSM1408193	c.460delG	p.G155fs*3	Deletion - Frameshift	Large_intestine
COSM4923603	c.438G>A	p.R146R	Substitution - coding silent	Liver
COSM3839581	c.215C>T	p.S72L	Substitution - Missense	Breast
COSM5776836	c.57G>A	p.G19G	Substitution - coding silent	Breast
COSM442940	c.770C>T	p.A257V	Substitution - Missense	Endometrium
COSM4572776	c.861T>A	p.N287K	Substitution - Missense	Skin
COSM5465571	c.523C>A	p.L175M	Substitution - Missense	Large_intestine
COSM5723567	c.129C>T	p.L43L	Substitution - coding silent	Skin
COSM721775	c.366A>T	p.T122T	Substitution - coding silent	Lung
COSM1021104	c.654C>A	p.V218V	Substitution - coding silent	Endometrium
COSM4624808	c.931C>A	p.L311I	Substitution - Missense	Large_intestine
COSM266138	c.787C>T	p.R263C	Substitution - Missense	Stomach
COSM5484549	c.609G>A	p.Q203Q	Substitution - coding silent	Large_intestine
COSM324885	c.593G>T	p.G198V	Substitution - Missense	Lung
COSM442940	c.770C>T	p.A257V	Substitution - Missense	Breast
COSM721774	c.762G>T	p.R254S	Substitution - Missense	Lung
COSM213616	c.791G>C	p.R264P	Substitution - Missense	Breast
COSM4779899	c.227G>T	p.G76V	Substitution - Missense	Liver
COSM333411	c.942G>A	p.P314P	Substitution - coding silent	Lung
COSM5723567	c.129C>T	p.L43L	Substitution - coding silent	Skin
COSM1178177	c.562C>A	p.Q188K	Substitution - Missense	Prostate
COSM5435708	c.215C>G	p.S72*	Substitution - Nonsense	Oesophagus
COSM4094352	c.927A>C	p.E309D	Substitution - Missense	Stomach
COSM3581800	c.903G>A	p.K301K	Substitution - coding silent	Skin
COSM3673695	c.491T>G	p.M164R	Substitution - Missense	Prostate
COSM5723567	c.129C>T	p.L43L	Substitution - coding silent	Skin
COSM1408193	c.460delG	p.G155fs*3	Deletion - Frameshift	Large_intestine
COSM3581797	c.289C>G	p.P97A	Substitution - Missense	Skin
COSM5517594	c.968G>C	p.G323A	Substitution - Missense	Biliary_tract
COSM4668971	c.791G>A	p.R264Q	Substitution - Missense	Large_intestine
COSM575243	c.632G>A	p.R211Q	Substitution - Missense	Biliary_tract
COSM5723567	c.129C>T	p.L43L	Substitution - coding silent	Skin
COSM3581798	c.318T>C	p.N106N	Substitution - coding silent	Skin
COSM1408194	c.912G>A	p.P304P	Substitution - coding silent	Large_intestine
COSM5883462	c.676G>C	p.D226H	Substitution - Missense	Breast
COSM1190995	c.938_939insA	p.Y313fs*1	Insertion - Frameshift	Lung
COSM4668970	c.149delA	p.K51fs*12	Deletion - Frameshift	Large_intestine
COSM5811704	c.554G>T	p.R185I	Substitution - Missense	Liver
COSM3185375	c.297C>A	p.Y99*	Substitution - Nonsense	Central_nervous_system
COSM4133851	c.79A>C	p.T27P	Substitution - Missense	Thyroid
COSM4094350	c.188G>C	p.R63T	Substitution - Missense	Stomach
COSM3185386	c.579G>A	p.R193R	Substitution - coding silent	Large_intestine
COSM5397061	c.384G>A	p.W128*	Substitution - Nonsense	Skin
COSM3185389	c.724A>G	p.S242G	Substitution - Missense	Upper_aerodigestive_tract
COSM1752570	c.196G>C	p.E66Q	Substitution - Missense	Urinary_tract
COSM5796979	c.381C>T	p.I127I	Substitution - coding silent	Breast
COSM4926441	c.771G>T	p.A257A	Substitution - coding silent	Liver
COSM1021106	c.716A>G	p.Y239C	Substitution - Missense	Endometrium
COSM3702194	c.958A>G	p.T320A	Substitution - Missense	Liver
COSM4094351	c.214T>C	p.S72P	Substitution - Missense	Stomach
COSM3185387	c.613A>G	p.I205V	Substitution - Missense	Large_intestine
COSM1752570	c.196G>C	p.E66Q	Substitution - Missense	Urinary_tract
COSM3185390	c.726C>T	p.S242S	Substitution - coding silent	Large_intestine
COSM368736	c.763-1G>T	p.?	Unknown	Lung
COSM5778581	c.85G>T	p.G29W	Substitution - Missense	Breast
COSM1021105	c.685A>G	p.M229V	Substitution - Missense	Endometrium
COSM4624807	c.763G>A	p.G255R	Substitution - Missense	Large_intestine
COSM5973803	c.781G>T	p.A261S	Substitution - Missense	Upper_aerodigestive_tract
COSM3185395	c.941C>T	p.P314L	Substitution - Missense	Oesophagus
COSM4856417	c.721G>T	p.A241S	Substitution - Missense	Cervix
COSM3839582	c.472A>G	p.T158A	Substitution - Missense	Breast
COSM1021107	c.933T>G	p.L311L	Substitution - coding silent	Endometrium
COSM3581799	c.763G>C	p.G255R	Substitution - Missense	Skin

> Text Mining based Variations [ TOP ]
There is no record for CAMKMT.

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Post-translational modification (PTM)

> Post-translational modification (PTM) [ TOP ]
There is no PTM data

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Expression analysis in primary tumor tissue from TCGA > Expression level in cancer cell line from CCLE > Expression level in human normal tissue from HPA > Text mining based expression change

> The Cancer Genome Atlas (TCGA)

Differential expression analysis for cancers with more than 10 normal samples

Cancer	Full Name	# N	# T	Median (N)	Median (T)	LogFC	Adj. P	Status
BLCA	Bladder urothelial carcinoma	19	408	2.03	2.413	0.295	0.129	NS
BRCA	Breast invasive carcinoma	112	1100	2.011	2.307	0.337	6.35e-07	NS
CESC	Cervical and endocervical cancers	3	306	2.225	2.418	NA	NA	NA
COAD	Colon adenocarcinoma	41	459	2.392	3.24	0.794	5.07e-14	Over
ESCA	Esophageal carcinoma	11	185	2.176	2.439	0.129	0.661	NS
GBM	Glioblastoma multiforme	5	166	2.684	2.321	NA	NA	NA
HNSC	Head and Neck squamous cell carcinoma	44	522	2.142	1.827	-0.212	0.0571	NS
KIRC	Kidney renal clear cell carcinoma	72	534	2.862	2.073	-0.896	1.26e-31	Under
KIRP	Kidney renal papillary cell carcinoma	32	291	2.84	2.682	-0.202	0.0664	NS
LAML	Acute Myeloid Leukemia	0	173	NA	1.976	NA	NA	NA
LGG	Brain Lower Grade Glioma	0	530	NA	2.101	NA	NA	NA
LIHC	Liver hepatocellular carcinoma	50	373	1.22	1.31	0.127	0.275	NS
LUAD	Lung adenocarcinoma	59	517	1.799	1.885	0.105	0.295	NS
LUSC	Lung squamous cell carcinoma	51	501	1.792	1.983	0.285	0.011	NS
OV	Ovarian serous cystadenocarcinoma	0	307	NA	2.953	NA	NA	NA
PAAD	Pancreatic adenocarcinoma	4	179	2.086	2.167	NA	NA	NA
PCPG	Pheochromocytoma and Paraganglioma	3	184	2.53	1.919	NA	NA	NA
PRAD	Prostate adenocarcinoma	52	498	1.799	1.818	0.028	0.793	NS
READ	Rectum adenocarcinoma	10	167	2.35	3.247	0.766	0.000302	Over
SARC	Sarcoma	2	263	2.708	1.756	NA	NA	NA
SKCM	Skin Cutaneous Melanoma	1	472	2.402	1.911	NA	NA	NA
STAD	Stomach adenocarcinoma	35	415	2.59	2.709	0.199	0.12	NS
TGCT	Testicular Germ Cell Tumors	0	156	NA	2.367	NA	NA	NA
THCA	Thyroid carcinoma	59	509	2.641	2.662	0.034	0.622	NS
THYM	Thymoma	2	120	2.213	2.633	NA	NA	NA
UCEC	Uterine Corpus Endometrial Carcinoma	35	546	2.304	3.559	1.256	1.63e-26	Over

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA)

Tissue	Expression Level (TPM)
Adipose tissue	5
Adrenal gland	6.3
Appendix	5.9
Bone marrow	6.9
Breast	7.3
Cerebral cortex	11.9
Cervix, uterine	9.8
Colon	7.5
Duodenum	6.3
Endometrium	8.2
Epididymis	8.6
Esophagus	6
Fallopian tube	8.8
Gallbladder	9.6
Heart muscle	3.3
Kidney	7.9
Liver	2.4
Lung	6.3
Lymph node	6.9
Ovary	5
Pancreas	2
Parathyroid gland	16.4
Placenta	5.2
Prostate	6.2
Rectum	8.5
Salivary gland	2.3
Seminal vesicle	6
Skeletal muscle	2.8
Skin	7.8
Small intestine	6.7
Smooth muscle	6.5
Spleen	6
Stomach	5.1
Testis	24.4
Thyroid gland	13.1
Tonsil	5.6
Urinary bladder	6.4

> Text Mining based Expression [ TOP ]
There is no record.

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Somatic copy number alteration in primary tomur tissue

> The Cancer Genome Atlas (TCGA)

Correlation between expression and SCNA as well as percentage of patients in different status.

Cancer	Full Name	# Sample	R	P	% Loss	% Neutral	% Gain	Status
BLCA	Bladder urothelial carcinoma	404	0.311	1.54e-10	6.9	61.4	31.7	Neutral
BRCA	Breast invasive carcinoma	1075	0.385	2.15e-39	15.3	69.3	15.4	Neutral
CESC	Cervical and endocervical cancers	292	0.346	1.21e-09	4.8	69.2	26	Neutral
COAD	Colon adenocarcinoma	449	0.327	1.12e-12	3.3	78.4	18.3	Neutral
ESCA	Esophageal carcinoma	183	0.199	0.0069	8.2	54.6	37.2	Gain
GBM	Glioblastoma multiforme	147	0.009	0.912	4.8	87.1	8.2	Neutral
HNSC	Head and Neck squamous cell carcinoma	514	0.153	0.000496	5.6	73.7	20.6	Neutral
KIRC	Kidney renal clear cell carcinoma	525	0.251	5.25e-09	3.2	82.5	14.3	Neutral
KIRP	Kidney renal papillary cell carcinoma	288	0.288	6.83e-07	2.4	83	14.6	Neutral
LAML	Acute Myeloid Leukemia	166	0.111	0.153	0.6	98.8	0.6	Neutral
LGG	Brain Lower Grade Glioma	513	0.064	0.149	4.3	92.6	3.1	Neutral
LIHC	Liver hepatocellular carcinoma	364	0.24	3.78e-06	9.3	76.9	13.7	Neutral
LUAD	Lung adenocarcinoma	512	0.263	1.55e-09	5.7	63.7	30.7	Neutral
LUSC	Lung squamous cell carcinoma	498	0.309	1.89e-12	3	45.6	51.4	Gain
OV	Ovarian serous cystadenocarcinoma	300	0.424	1.6e-14	11	41.7	47.3	Gain
PAAD	Pancreatic adenocarcinoma	177	0.277	0.000186	8.5	83.1	8.5	Neutral
PCPG	Pheochromocytoma and Paraganglioma	162	0.183	0.0196	6.2	90.1	3.7	Neutral
PRAD	Prostate adenocarcinoma	491	0.29	5.98e-11	8.6	88.6	2.9	Neutral
READ	Rectum adenocarcinoma	164	0.34	8.3e-06	8.5	68.3	23.2	Neutral
SARC	Sarcoma	255	0.3	1.03e-06	32.9	54.9	12.2	Neutral
SKCM	Skin Cutaneous Melanoma	367	0.155	0.00288	14.7	67	18.3	Neutral
STAD	Stomach adenocarcinoma	413	0.342	9.04e-13	6.5	74.3	19.1	Neutral
TGCT	Testicular Germ Cell Tumors	150	0.405	2.75e-07	4	57.3	38.7	Gain
THCA	Thyroid carcinoma	497	0.219	8.54e-07	2	97.6	0.4	Neutral
THYM	Thymoma	119	0.112	0.226	0.8	98.3	0.8	Neutral
UCEC	Uterine Corpus Endometrial Carcinoma	537	0.301	1.06e-12	2.4	75.8	21.8	Neutral

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Methylation level in the promoter region of CR

> Methylation level in the promoter region of CR

Correlation between expression and methylation as well as differential methylation analysis.

Cancer	Full Name	R	P	# N	# T	Delta beta (T vs N)	P value (T vs N)	Status
BLCA	Bladder urothelial carcinoma	-0.177	0.000244	17	408	0	0.745	NS/NA
BRCA	Breast invasive carcinoma	-0.128	0.000158	83	785	-0.001	0.00988	NS/NA
CESC	Cervical and endocervical cancers	-0.228	5.33e-05	3	306	NA	NA	NS/NA
COAD	Colon adenocarcinoma	-0.161	0.00417	19	297	0	0.878	NS/NA
ESCA	Esophageal carcinoma	-0.198	0.00575	9	185	NA	NA	NS/NA
GBM	Glioblastoma multiforme	-0.262	0.0353	1	64	NA	NA	NS/NA
HNSC	Head and Neck squamous cell carcinoma	-0.213	6.07e-07	20	522	0.001	0.0557	NS/NA
KIRC	Kidney renal clear cell carcinoma	-0.305	9.38e-09	24	319	0.005	0.00367	NS/NA
KIRP	Kidney renal papillary cell carcinoma	-0.133	0.0212	23	275	-0.008	0.000305	NS/NA
LAML	Acute Myeloid Leukemia	-0.162	0.0354	0	170	NA	NA	NS/NA
LGG	Brain Lower Grade Glioma	-0.103	0.0174	0	530	NA	NA	NS/NA
LIHC	Liver hepatocellular carcinoma	-0.037	0.456	41	373	0.002	0.101	NS/NA
LUAD	Lung adenocarcinoma	-0.113	0.014	21	456	-0.009	0.621	NS/NA
LUSC	Lung squamous cell carcinoma	-0.202	7.77e-05	8	370	NA	NA	NS/NA
OV	Ovarian serous cystadenocarcinoma	-0.767	0.0214	0	9	NA	NA	NS/NA
PAAD	Pancreatic adenocarcinoma	-0.163	0.0273	4	179	NA	NA	NS/NA
PCPG	Pheochromocytoma and Paraganglioma	-0.061	0.408	3	184	NA	NA	NS/NA
PRAD	Prostate adenocarcinoma	-0.104	0.016	35	498	-0.003	0.159	NS/NA
READ	Rectum adenocarcinoma	-0.226	0.0232	2	99	NA	NA	NS/NA
SARC	Sarcoma	-0.223	0.000281	0	263	NA	NA	NS/NA
SKCM	Skin Cutaneous Melanoma	-0.106	0.0218	1	471	NA	NA	NS/NA
STAD	Stomach adenocarcinoma	-0.219	2.05e-05	0	372	NA	NA	NS/NA
TGCT	Testicular Germ Cell Tumors	-0.191	0.0173	0	156	NA	NA	NS/NA
THCA	Thyroid carcinoma	-0.102	0.0159	50	509	-0.002	0.107	NS/NA
THYM	Thymoma	-0.147	0.105	2	120	NA	NA	NS/NA
UCEC	Uterine Corpus Endometrial Carcinoma	-0.132	0.00436	34	431	-0.004	0.0921	NS/NA

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Primary tumor tissue from TCGA > Normal tumor tissue from HPA

>The Cancer Genome Atlas (TCGA) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA) [ TOP ]
There is no antibody staining data.

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Association between expresson and subtype > Overall survival analysis based on expression > Association between expresson and stage > Association between expresson and grade

> Subtype

Association between expresson and subtype.

Cancer	Full Name	# Patients	P Value (Kruskal-Wallis)	Association	Source
BLCA	Bladder urothelial carcinoma	128	0.481	NS	24476821
BRCA	Breast invasive carcinoma	521	1.21e-09	Significant	23000897
COAD	Colon adenocarcinoma	149	2.53e-06	Significant	22810696
GBM	Glioblastoma multiforme	157	0.0637	NS	26824661
HNSC	Head and Neck squamous cell carcinoma	279	0.00205	Significant	25631445
KIRP	Kidney renal papillary cell carcinoma	161	0.829	NS	26536169
LGG	Brain Lower Grade Glioma	513	1.63e-25	Significant	26824661
LUAD	Lung adenocarcinoma	230	8.48e-07	Significant	25079552
LUSC	Lung squamous cell carcinoma	178	0.134	NS	22960745
OV	Ovarian serous cystadenocarcinoma	287	7.04e-06	Significant	21720365
PRAD	Prostate adenocarcinoma	333	0.255	NS	26544944
READ	Rectum adenocarcinoma	67	0.0113	Significant	22810696
SKCM	Skin Cutaneous Melanoma	315	0.000219	Significant	26091043
STAD	Stomach adenocarcinoma	277	9.32e-05	Significant	25079317
THCA	Thyroid carcinoma	391	1.95e-19	Significant	25417114
UCEC	Uterine Corpus Endometrial Carcinoma	232	0.0099	Significant	23636398

> Overall survival

Overall survival analysis based on expression.

Cancer	Full Name	# Patients	Hazard Ratio	P Value (Log Rank Test)	Association
BLCA	Bladder urothelial carcinoma	405	0.91	0.667	NS
BRCA	Breast invasive carcinoma	1079	0.993	0.975	NS
CESC	Cervical and endocervical cancers	291	0.977	0.945	NS
COAD	Colon adenocarcinoma	439	0.857	0.582	NS
ESCA	Esophageal carcinoma	184	1.265	0.444	NS
GBM	Glioblastoma multiforme	158	0.576	0.0293	Longer
HNSC	Head and Neck squamous cell carcinoma	518	1.197	0.354	NS
KIRC	Kidney renal clear cell carcinoma	531	1.28	0.235	NS
KIRP	Kidney renal papillary cell carcinoma	287	0.651	0.301	NS
LAML	Acute Myeloid Leukemia	149	0.947	0.861	NS
LGG	Brain Lower Grade Glioma	511	2.319	0.000664	Shorter
LIHC	Liver hepatocellular carcinoma	365	1.229	0.396	NS
LUAD	Lung adenocarcinoma	502	0.786	0.236	NS
LUSC	Lung squamous cell carcinoma	494	0.59	0.00847	Longer
OV	Ovarian serous cystadenocarcinoma	303	0.924	0.705	NS
PAAD	Pancreatic adenocarcinoma	177	1.383	0.278	NS
PCPG	Pheochromocytoma and Paraganglioma	179	0.994	0.995	NS
PRAD	Prostate adenocarcinoma	497	3.606	0.227	NS
READ	Rectum adenocarcinoma	159	0.676	0.498	NS
SARC	Sarcoma	259	0.976	0.934	NS
SKCM	Skin Cutaneous Melanoma	459	1.442	0.0624	NS
STAD	Stomach adenocarcinoma	388	0.676	0.0848	NS
TGCT	Testicular Germ Cell Tumors	134	0	0.173	NS
THCA	Thyroid carcinoma	500	0.671	0.574	NS
THYM	Thymoma	119	1.932	0.584	NS
UCEC	Uterine Corpus Endometrial Carcinoma	543	0.887	0.655	NS

> Stage

Association between expresson and stage.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
BLCA	Bladder urothelial carcinoma	406	-0.084	0.0923	NS
BRCA	Breast invasive carcinoma	1071	-0.025	0.407	NS
CESC	Cervical and endocervical cancers	167	-0.035	0.656	NS
COAD	Colon adenocarcinoma	445	0.101	0.0338	Higher
ESCA	Esophageal carcinoma	162	-0.064	0.418	NS
HNSC	Head and Neck squamous cell carcinoma	448	0.046	0.332	NS
KIRC	Kidney renal clear cell carcinoma	531	0.063	0.147	NS
KIRP	Kidney renal papillary cell carcinoma	260	-0.081	0.194	NS
LIHC	Liver hepatocellular carcinoma	347	0.049	0.359	NS
LUAD	Lung adenocarcinoma	507	-0.061	0.169	NS
LUSC	Lung squamous cell carcinoma	497	0.072	0.107	NS
OV	Ovarian serous cystadenocarcinoma	302	0.125	0.03	Higher
PAAD	Pancreatic adenocarcinoma	176	0.041	0.587	NS
READ	Rectum adenocarcinoma	156	0.04	0.621	NS
SKCM	Skin Cutaneous Melanoma	410	-0.113	0.022	Lower
STAD	Stomach adenocarcinoma	392	-0.129	0.0104	Lower
TGCT	Testicular Germ Cell Tumors	81	-0.063	0.578	NS
THCA	Thyroid carcinoma	499	-0.006	0.897	NS
UCEC	Uterine Corpus Endometrial Carcinoma	501	0	0.995	NS

> Grade

Association between expresson and grade.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
CESC	Cervical and endocervical cancers	272	-0.014	0.814	NS
HNSC	Head and Neck squamous cell carcinoma	498	-0.027	0.547	NS
KIRC	Kidney renal clear cell carcinoma	525	0.065	0.137	NS
LGG	Brain Lower Grade Glioma	514	0.141	0.00136	Higher
LIHC	Liver hepatocellular carcinoma	366	0.077	0.143	NS
OV	Ovarian serous cystadenocarcinoma	296	0.048	0.409	NS
PAAD	Pancreatic adenocarcinoma	176	-0.006	0.938	NS
STAD	Stomach adenocarcinoma	406	-0.227	3.77e-06	Lower
UCEC	Uterine Corpus Endometrial Carcinoma	534	-0.01	0.824	NS

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Targets inferred by reverse engineering method > Targets identified by ChIP-seq data

> Targets inferred by reverse engineering method [ TOP ]

> Targets identified by ChIP-seq data [ TOP ]

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Drugs from DrugBank database

> Drugs from DrugBank database [ TOP ]
There is no record for CAMKMT.

Summary
Symbol	CAMKMT
Name	calmodulin-lysine N-methyltransferase
Aliases	CLNMT; CaM KMT; C2orf34; chromosome 2 open reading frame 34; KMT
Location	2p21
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Protein-Protein Interaction Network > miRNA Regulatory Relationship > Interactions from Text Mining

> Protein-Protein Interaction Network [ TOP ]

> miRNA Regulatory Relationship [ TOP ]
There is no record for CAMKMT.

> Interactions from Text Mining [ TOP ]
There is no record for CAMKMT.